ViralVacDB | Details of Viral Vaccine

Details of Viral Vaccine

This Viral vaccine card gives comprehensive information about each vaccine.
Detailed Information
ID10191
Vaccine NameV590-001
Disease NameCOVID-19
Disease ClassificationRespiratory
Virus NameSARS-CoV-2 virus
Nucleic Acid Contentpositive-sense, single-stranded RNA
Vaccine TypeReplicating viral vector
Vaccine StatusPhase 1
ManufacturerMerck & Co. Inc.
Year of Manufacturing2020
Manufacturing CountryUSA
Age18 years and above
DosageNA
Administration RouteIntramuscular
AdjuvantNA
Target StrainNA
DescriptionNA
Approving OrganisationUS FDA
Collaborating OrganisationNA
Other CountriesNA
Trade NameNA
PMIDNA
Clinical Trial IDNCT04569786
Reference Linkhttps://clinicaltrials.gov/show/NCT04569786
Additional LinksNA